| Product Code: ETC9409327 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Nucleic Acid Therapeutics CDMO Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Nucleic Acid Therapeutics CDMO Market - Industry Life Cycle |
3.4 South Korea Nucleic Acid Therapeutics CDMO Market - Porter's Five Forces |
3.5 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.7 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
3.8 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 South Korea Nucleic Acid Therapeutics CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing research and development activities in nucleic acid therapeutics in South Korea |
4.2.2 Rising prevalence of genetic disorders and chronic diseases driving the demand for nucleic acid therapeutics |
4.2.3 Growing investments in the biopharmaceutical sector in South Korea |
4.3 Market Restraints |
4.3.1 Regulatory challenges and stringent approval processes for nucleic acid therapeutics |
4.3.2 High costs associated with the development and manufacturing of nucleic acid therapeutics |
5 South Korea Nucleic Acid Therapeutics CDMO Market Trends |
6 South Korea Nucleic Acid Therapeutics CDMO Market, By Types |
6.1 South Korea Nucleic Acid Therapeutics CDMO Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.1.4 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By RNA-based Therapies, 2021- 2031F |
6.2 South Korea Nucleic Acid Therapeutics CDMO Market, By Service |
6.2.1 Overview and Analysis |
6.2.2 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Process Development and Optimization, 2021- 2031F |
6.2.3 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Manufacturing Services, 2021- 2031F |
6.2.4 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Analytical and Quality Control Services, 2021- 2031F |
6.2.5 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 South Korea Nucleic Acid Therapeutics CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.3.3 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Government & Academic Research Institutes, 2021- 2031F |
6.3.4 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.4 South Korea Nucleic Acid Therapeutics CDMO Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Oncology, 2021- 2031F |
6.4.3 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Genetic Disorders, 2021- 2031F |
6.4.4 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.4.5 South Korea Nucleic Acid Therapeutics CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 South Korea Nucleic Acid Therapeutics CDMO Market Import-Export Trade Statistics |
7.1 South Korea Nucleic Acid Therapeutics CDMO Market Export to Major Countries |
7.2 South Korea Nucleic Acid Therapeutics CDMO Market Imports from Major Countries |
8 South Korea Nucleic Acid Therapeutics CDMO Market Key Performance Indicators |
8.1 Number of partnerships and collaborations between nucleic acid therapeutics companies and CDMOs in South Korea |
8.2 Percentage increase in research funding for nucleic acid therapeutics in South Korea |
8.3 Rate of adoption of nucleic acid therapeutics in clinical trials in South Korea |
9 South Korea Nucleic Acid Therapeutics CDMO Market - Opportunity Assessment |
9.1 South Korea Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 South Korea Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.3 South Korea Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
9.4 South Korea Nucleic Acid Therapeutics CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
10 South Korea Nucleic Acid Therapeutics CDMO Market - Competitive Landscape |
10.1 South Korea Nucleic Acid Therapeutics CDMO Market Revenue Share, By Companies, 2024 |
10.2 South Korea Nucleic Acid Therapeutics CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here